Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity

NCT05956509 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic considerations

Conditions

Upper Limb Spasticity

Interventions

BIOLOGICAL: ABBV-950
BIOLOGICAL: BOTOX
DRUG: Placebo for ABBV-950

Sponsor

AbbVie